CardiofaxV ECG-2450


Quality of diagnosis High accuracy of analysis and noiseless technology enable better care decision-making and eliminate the need to retest. Help better care decision-making Nihon Kohden’s ECAPS 12C ECG analysis program has over 200 findings and 5 judgement categories with detailed analysis. ECAPS 12C can also detect Brugada-type ECG pattern. Identify invisible ischemia International guidelines such as AHA, ACC and ESC recommend measuring additional leads (V3R-V5R, V7-V9) for patients with suspected acute coronary syndrome. Actual 15-lead ECG can be measured on ECG-2450 which can measure selected 3-lead in addition to 12-lead ECG. However, additional workload or patient immobility make the additional leads absent in a routine patient care. To make the benefits of additional leads more readily available, Nihon Kohden’s innovative synECi synthesized 18-lead ECG technology mathematically derives the waveforms of the right chest leads (V3R, V4R, V5R) and back leads (V7, V8, V9) from the standard 12-lead ECG with no additional workload and no additional electrodes. Synthesized 18-lead ECG can help you catch significant ST elevation on right ventricular or posterior wall. Identify the risk of sudden death Recording late potentials is helpful for assessing dangerous heart rhythm which may lead to cardiac sudden death. The optional signal average ECG software can show the late potentials which are too small to be recorded by standard 12-lead ECG. Also, Nihon Kohden's ECAPS 12C ECG analysis program can detect Brugada type ECG pattern as another cause of sudden cardiac death without the optional software. ECG-2450 can help identify the risk of sudden cardiac death by severe arrhythmia without obvious cause.
Visit ID (prod)